PSI reveals list of drugs withdrawn from market due to possible carcinogenicity | National



[ad_1]

This article contains important medical information, but never forget to see your doctor.

The Institute of Public Health (ISP) ordered the preventive removal of drugs against high blood pressure containing Valsartan, due to the presence of an impurity that could cause cancer.

The problem was caused by a change in the manufacturing process of the active ingredient manufactured by Zhejing Huahai Pharmaceutical Co. China which was distributed by them to laboratories all over the world.

Those who consume these drugs should not stop their treatment as they should consult their doctor for a replacement, says the ISP. After the announcement, the health authority detailed the list of drugs concerned.

In the case of Eurofarma Chile S.A the measure affects the coated tablets of Valsartan 80 mg and Veralpres Coated Tablets 160 mg.

For its part, Chemopharma S.A is to remove Micten D-160 / 12.5 Coated Tablets and Micten D-80 / 12.5 Coated Tablets.

Also, Chile Laboratory SA will take market Amplex coated tablets 10/160, Amplex coated tablets 5/160, Amplex coated tablets 5/80, Amplex coated tablets D10 / 160 / 12.5, tablets Amplex D5 / 160 / 12.5 coated tablets, Valaplex 320 mg coated tablets, Valaplex 160mg coated tablets (valsartan), Valaplex 80mg coated tablets, Valaplex-D 160 / 12.5mg coated tablets, Valaplex D 80 / 12.5 coated tablets and tablets Mixed Valaplex D Forte 160/25

sum Vartalan D Strong coated tablets, Vartalan D coated tablets, Vartalan D-Plus 160/25 coated tablets, Vartalan coated tablets 320mg, Vartalan-D coated tablets, Vartalan D coated tablets 160mg, Vartalan Coated tablets 80mg, Vartalan AM 10/160 coated tablets, Vartalan AM 5/160 coated tablets, Vartalan AM 5/320 coated tablets and Vartalan AM 5/80 coated tablets.

Vartalan AM D 5/160 / 12.5 Capsules and Vartalan AM D 10/160 / 12.5 Capsules are included in this long list of this laboratory.

In addition, Galenicum Health Chili SpA should do the same with Valvitae Coated Tablets 80mg, Valvitae Coated Tablets 160mg, Valvitae Plus 80 / 12.5 Coated Tablets, Valvitae Plus 160 / 12.5 Coated Tablets and In the same way, Laboratorios Andrómaco SA will do the same with Dosara D-Forte coated tablets.

Pharma Investi de Chile SA will have to withdraw from the market Ampliron VL 5/80 Capsules, Capsules Ampliron VL 5/160, Capsules Ampliron VL 10/160, Capsules Ampliron VL H 5/160 / 12.5, Capsules Ampliron VL H 10/160 / 12.5, Ampliron VL H 10/160 Coated Tablets, Ampliron VL H 5/80 Coated Tablets, Ampliron VL H 10/160 / 12.5 Coated Tablets, Ampliron VL H 5/160 / 12 Coated Tablets , 5 and Ampliron Tablets VL 5/160 Coated

According to the ISP, the laboratory Mintlab Co. SA it is not affected by the withdrawal measure, since 39, to date, they do not have any current lots on the market.

The entity also noted that Laboratorio Lafi Ltda Laboratorio Recalcine SA and Laboratorios Recalcine SA have voluntarily started the recall of their products before the l '; recall instruction.

Lots removed

If you consume any of these medications, you may want to check out the detailed list of lots affected by the withdrawal order.

[ad_2]
Source link